KYMR
Kymera Therapeutics, Inc.
Stock
$107.39−2.73 (−2.48%)Close Oct 2, 2026
- Operating income, 2025
- −$349M
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | −$349M | — |
| 2024 | −$262M | — |
| 2023 | −$166M | — |
| 2022 | −$161M | — |
| 2021 | −$101M | — |
| 2020 | −$46M | — |
| 2019 | −$42M | — |